Buch, Englisch, Band 171, 128 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 377 g
Buch, Englisch, Band 171, 128 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 377 g
Reihe: Cancer Treatment and Research
ISBN: 978-3-319-43894-8
Verlag: Springer International Publishing
Describes the latest thoughts and findings relating to drug safety in the cancer domain
Covers emerging strategies to identify adverse drug reactions and drug-drug interactions
Highlights policies instituted to improve cancer patient safety
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Pharmacovigilance programs: Do they improve Cancer Drug Safety?.- Impact of Cost on the Safety of Cancer pharmaceuticals.- Assessing pharmaceutical safety in Geriatric Oncology.- Cancer co-Morbidity: Implications for Drug Safety.- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions?.- Pharmacovigilance of alternative medications in the Cancer Setting.- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology.- Biosimilars: Are they really safe?.- Natural Language processing: improving the identification and communication of Cancer Drug Safety.- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety.- Anatomy of Risk Evaluation and Mitigation Strategies (REMS).- Cancer Drug Toxicity: Moving from patient to Survivor.
